Log in to save to my catalogue

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_db50928aa4074b2abd325527228f1f9a

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease

About this item

Full title

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2022-01, Vol.11 (3), p.389

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Amyloid-beta (Aβ) deposition in the brain is closely linked with the development of Alzheimer’s disease (AD). Unfortunately, therapies specifically targeting Aβ deposition have failed to reach their primary clinical endpoints, emphasizing the need to broaden the search strategy for alternative targets/mechanisms. Transglutaminase-2 (TG2) catalyzes...

Alternative Titles

Full title

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_db50928aa4074b2abd325527228f1f9a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_db50928aa4074b2abd325527228f1f9a

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells11030389

How to access this item